Soumya Jyoti Singha Roy

Soumya Jyoti Singha Roy

Auto-generated profile, based on publicly available information

Soumya Jyoti Singha Roy

Boston College

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
AOArianna O. Osgood
Arianna O. Osgood
YZYunan Zheng
Yunan Zheng
SRSoumya Jyoti Singha Roy
Soumya Jyoti Singha Roy
NBNikolaos Biris
Nikolaos Biris
MHMyer Hussain
Myer Hussain
ACAbhishek Chatterjee
Abhishek Chatterjee

30 March 2022 in ACS Central Science
Verified
Journal Article
Open access
KGKatherine T. Grasso
Katherine T. Grasso
SRSoumya Jyoti Singha Roy
Soumya Jyoti Singha Roy
AOArianna O. Osgood
Arianna O. Osgood
MYMegan Jin Rae Yeo
Megan Jin Rae Yeo
CSChintan Soni
Chintan Soni
ACAbhishek Chatterjee
Abhishek Chatterjee
The Escherichia coli tyrosyl-tRNA synthetase (EcTyrRS)/tRNAEcTyr pair offers an attractive platform for genetically encoding new noncanonical amino acids (ncAA) in eukaryotes. However, challenges associated with a eukaryotic selection system, which is needed to engineer the platform, have impeded its success in the past. Recently, using a facile E. coli-based selection system, we showed that EcTyrRS could be engineered in a strain where the endogenous tyrosyl pair was substituted with an archaeal counterpart. However, significant cross-reactivity between the UAG-suppressing tRNACUAEcTyr and the bacterial glutaminyl-tRNA synthetase limited the scope of this strategy, preventing the selection of moderately active EcTyrRS mutants. Here we report an engineered tRNACUAEcTyr that overcomes this cross-reactivity. Optimized selection systems based on this tRNA enabled the efficient enrichment of both strongly and weakly active ncAA-selective EcTyrRS mutants. We also developed a wide dynamic range (WiDR) antibiotic selection to further enhance the activities of the weaker first-generation EcTyrRS mutants. We demonstrated the utility of our platform by developing several new EcTyrRS mutants that efficiently incorporated useful ncAAs in mammalian cells, including photoaffinity probes, bioconjugation handles, and a nonhydrolyzable mimic of phosphotyrosine.

9 September 2024 in ACS Chemical Biology
Verified
Journal Article
Open access
LCLi-Yun Chen
Li-Yun Chen
SRSoumya Jyoti Singha Roy
Soumya Jyoti Singha Roy
AJAppaso M. Jadhav
Appaso M. Jadhav
WWWesley W. Wang
Wesley W. Wang
PCPei-Hsin Chen
Pei-Hsin Chen
CPChristopher G. Parker
Christopher G. Parker

21 June 2024 in ACS Synthetic Biology
Verified
Journal Article
Closed access
RHRachel L. Huang
Rachel L. Huang
DJDelilah Jewel
Delilah Jewel
RKRachel E. Kelemen
Rachel E. Kelemen
QPQuan Pham
Quan Pham
TYTarah J. Yared
Tarah J. Yared
ACAbhishek Chatterjee
Abhishek Chatterjee

13 August 2025 in Accounts of Chemical Research
Verified
Journal Article
Closed access
WWWesley W. Wang
Wesley W. Wang
SRSoumya Jyoti Singha Roy
Soumya Jyoti Singha Roy
CPChristopher G. Parker
Christopher G. Parker

28 March 2024 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AOArianna O. Osgood
Arianna O. Osgood
SRSoumya Jyoti Singha Roy
Soumya Jyoti Singha Roy
DKDavid Koo
David Koo
RGRenpeng Gu
Renpeng Gu
ACAbhishek Chatterjee
Abhishek Chatterjee